Total Payments
$12,578
2024 Payments
$1,415
Companies
43
Transactions
332
Medicare Patients
3,437
Medicare Billing
$984,197
Payment Breakdown by Category
Food & Beverage$6,045 (48.1%)
Gifts$1,973 (15.7%)
Education$1,795 (14.3%)
Other$1,515 (12.0%)
Consulting$1,225 (9.7%)
Travel$25.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,045 | 276 | 48.1% |
| Gift | $1,973 | 15 | 15.7% |
| Education | $1,795 | 22 | 14.3% |
| Long term medical supply or device loan | $1,515 | 17 | 12.0% |
| Consulting Fee | $1,225 | 1 | 9.7% |
| Travel and Lodging | $25.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,778 | 46 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,643 | 8 | $0 (2022) |
| Janssen Biotech, Inc. | $820.21 | 32 | $0 (2024) |
| Incyte Corporation | $717.28 | 10 | $0 (2024) |
| GENZYME CORPORATION | $626.02 | 25 | $0 (2024) |
| PFIZER INC. | $546.73 | 27 | $0 (2024) |
| Eisai Inc. | $434.26 | 23 | $0 (2024) |
| Astellas Pharma US Inc | $412.69 | 10 | $0 (2023) |
| Amgen Inc. | $406.51 | 16 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $387.95 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,415 | 61 | PFIZER INC. ($194.59) |
| 2023 | $1,789 | 69 | Novartis Pharmaceuticals Corporation ($280.58) |
| 2022 | $2,060 | 77 | Novartis Pharmaceuticals Corporation ($384.09) |
| 2021 | $2,383 | 60 | Novartis Pharmaceuticals Corporation ($1,081) |
| 2020 | $251.77 | 9 | Novartis Pharmaceuticals Corporation ($99.70) |
| 2019 | $1,388 | 17 | Novartis Pharmaceuticals Corporation ($989.14) |
| 2018 | $2,862 | 26 | Takeda Pharmaceuticals U.S.A., Inc. ($1,523) |
| 2017 | $429.44 | 13 | Incyte Corporation ($99.95) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: Hematology/Oncology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Oncology | ||||||
| 11/11/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Oncology | ||||||
| 11/04/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $19.91 | General |
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Oncology | ||||||
| 10/28/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $44.42 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/03/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Oncology | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 08/05/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | Azurity Pharmaceuticals, Inc. | VIVIMUSTA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.66 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 907 | 3,570 | $465,128 | $225,234 |
| 2022 | 15 | 897 | 4,077 | $506,401 | $233,777 |
| 2021 | 14 | 801 | 4,039 | $514,918 | $248,491 |
| 2020 | 14 | 832 | 4,268 | $601,466 | $276,696 |
Total Patients
3,437
Total Services
15,954
Medicare Billing
$984,197
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 107 | 487 | $7,300 | $1,443 | 19.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,054 | $1,091 | 35.7% |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 2022 | 20 | 175 | $1.75 | $1.74 | 99.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 17 | 111 | $1.11 | $1.11 | 100.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 138 | 656 | $146,940 | $63,612 | 43.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 102 | 853 | $132,271 | $57,839 | 43.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 647 | $81,766 | $54,097 | 66.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 105 | 121 | $35,545 | $22,778 | 64.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 16 | 165 | $24,425 | $11,881 | 48.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 86 | $15,025 | $10,433 | 69.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 27 | 137 | $11,220 | $7,092 | 63.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 44 | 367 | $20,185 | $4,873 | 24.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 29 | 34 | $8,670 | $4,398 | 50.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2021 | 15 | 157 | $15,400 | $3,364 | 21.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $4,450 | $2,939 | 66.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 20 | $5,851 | $1,922 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 26 | $5,223 | $1,677 | 32.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 103 | 528 | $7,945 | $1,584 | 19.9% |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 2021 | 14 | 141 | $1.41 | $1.41 | 100.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 14 | 83 | $0.83 | $0.83 | 100.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 166 | 1,121 | $251,385 | $109,271 | 43.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 669 | $84,650 | $45,645 | 53.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 138 | 151 | $44,405 | $28,405 | 64.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 67 | 402 | $62,310 | $27,257 | 43.7% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 14 | 134 | $33,500 | $18,804 | 56.1% |
About Dr. Hitendra Rambhia, MD
Dr. Hitendra Rambhia, MD is a Hematology & Oncology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629061155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hitendra Rambhia, MD has received a total of $12,578 in payments from pharmaceutical and medical device companies, with $1,415 received in 2024. These payments were reported across 332 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,045).
As a Medicare-enrolled provider, Rambhia has provided services to 3,437 Medicare beneficiaries, totaling 15,954 services with total Medicare billing of $984,197. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Brooklyn, NY
- Active Since 08/30/2005
- Last Updated 10/22/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629061155
Products in Payments
- KISQALI (Drug) $3,407
- NINLARO (Drug) $1,433
- Lenvima (Drug) $434.26
- JEVTANA (Drug) $427.02
- DARZALEX (Biological) $328.38
- ERLEADA (Drug) $306.58
- OPDIVO (Biological) $262.72
- SARCLISA (Biological) $203.95
- Nplate (Biological) $203.38
- BOSULIF (Drug) $181.35
- LUMAKRAS (Drug) $159.57
- KEYTRUDA (Biological) $147.51
- Doptelet (Drug) $143.66
- XTANDI (Drug) $130.33
- KRAZATI (Drug) $128.72
- TAGRISSO (Drug) $125.77
- XALKORI (Drug) $114.60
- IBRANCE (Drug) $113.49
- VELCADE (Drug) $111.24
- IMBRUVICA (Drug) $105.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brooklyn
Perry Cook, M.d, M.D
Hematology & Oncology — Payments: $1.4M
Hematology & Oncology $1.4M
Yiwu Huang, Md, MD
Hematology & Oncology — Payments: $268,275
Hematology & Oncology $268,275
Dr. Ilya Blokh, M.d, M.D
Hematology & Oncology — Payments: $191,276
Hematology & Oncology $191,276
Songchuan Guo, M.d, M.D
Hematology & Oncology — Payments: $106,907
Hematology & Oncology $106,907
Yiqing Xu, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $51,145
Hematology & Oncology $51,145
Dr. Azriel Hirschfeld, M.d, M.D
Hematology & Oncology — Payments: $48,699
Hematology & Oncology $48,699